| [1] |
World Health Organization. Global tuberculosis report 2018. Geneva: World Health Organization, 2018.
|
| [2] |
中华人民共和国卫生健康委员会疾病预防控制局. 2018 年全国法定传染病疫情概况. 2019-02-10.
doi: 10.3969/j.issn.1006-5180.2013.13.003
URL
|
| [3] |
唐神结, 谭守勇, 吴琦 , 等. 中国结核病临床诊断与治疗80年历程回顾. 中华结核和呼吸杂志, 2017,40(5):327-333.
doi: 10.3760/cma.j.issn.1001-0939.2017.05.003
URL
|
| [4] |
靳晓伟, 魏强, 靳鸿建 . 新形势下我国结核病防治结合控制工作面临的问题及对策. 结核病与肺部健康杂志, 2017,6(4):310-317.
|
| [5] |
刘宇红, 杜建, 唐神结 , 等. 信息化与结核病防治. 结核病与肺部健康杂志, 2016,5(1):12-13.
doi: 10.3969/j.issn.2095-3755.2016.01.005
URL
|
| [6] |
刘盛元, 谭卫国, 杨亚蕊 , 等. 重视信息化技术应用促进结核病防治工作. 结核病与肺部健康杂志, 2018,7(1):3-8.
|
| [7] |
Tacconelli E, Carrara E, Savoldi A , et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis, 2018,18(3):318-327.
doi: 10.1016/S1473-3099(17)30753-3
URL
pmid: 29276051
|
| [8] |
Dorman SE, Schumacher SG, Alland D , et al. Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Lancet Infect Dis, 2018,18(1):76-84.
doi: 10.1016/S1473-3099(17)30691-6
URL
pmid: 29198911
|
| [9] |
World Health Organization. The use of molecular line probe assays for the detection of resistance to second-line anti-tuberculosis drugs. Policy guidance. Geneva: World Health Organization, 2016.
|
| [10] |
World Health Organization. The use of next-generation sequencing technologies for the detection of mutations associated with drug resistance in Mycobacterium tuberculosis complex: technical guide. Geneva: World Health Organization, 2018.
|
| [11] |
World Health Organization. WHO treatment guidelines for multidrug- and rifampicin-resistant tuberculosis.2018 update pre-final text. Geneva: World Health Organization, 2018.
|
)
京公安网备11010202008787号
ip访问总数: ip当日访问总数: 当前在线人数:
本作品遵循Creative Commons Attribution 3.0 License授权许可
